Surgery Partners Overview
Surgery Partners Target Price
Analysts' 12-month price predictions for SGRY.
Get informed when a big investor buys or sells
+ FollowShare Price
$14.53
Average Target Price
$19.88
36.8% upside
36.8% upside6 analysts in the last 4 months
High: $30 | Low: $15
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-06 | Jefferies | $17 | 17% upside |  |
| 2026-04-20 | Jefferies | $15 | 3.2% upside | |
| 2026-03-11 | US Capital Advisors | $21 | 44.5% upside | |
| 2026-03-04 | JefferiesBrian Tanquilut | $16.25 | 11.8% upside | |
| 2026-03-04 | RBC CapitalBen Hendrix | $20 | 37.6% upside | |
| 2026-03-03 | Jefferies | $30 | 106.5% upside | |
| 2025-12-18 | Mizuho Securities | $19 | 30.8% upside | |
| 2025-11-21 | Barclays | $18 | 23.9% upside | |
| 2025-11-17 | Mizuho Securities | $22 | 51.4% upside | |
| 2024-11-13 | JefferiesBrian Tanquilut | $40 | 175.3% upside | |
| 2024-11-13 | BarclaysAndrew Mok | $31 | 113.4% upside | |
| 2024-10-14 | UBSAJ Rice | $38 | 161.5% upside | |
| 2024-06-28 | MacquarieTao Qiu | $31 | 113.4% upside | |
| 2022-05-04 | Citigroup | $64 | 340.5% upside | |